H

Hennepin Healthcare Research Institute | Cardiac Biomarker Trials Laboratory

Research site

(Unclaimed)

Location

914 South 8th Street, Minneapolis, Minnesota, United States of America

Site insights

Top conditions

Top treatments

Remdesivir

Nicotine

Buprenorphine

Danicopan

Ibudilast

AMX0035

S-217622

MN-166

Parent organization

This site is a part of Hennepin Healthcare Research Institute

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 26 total trials

Evaluation of MN-166 (Ibudilast) for 12 Months Followed by an Open-label Extension for 6 Months in Patients With ALS (COMBAT-ALS)

A Phase 2b/3 multicenter, randomized, double-blind, placebo-controlled, parallel group study to evaluate the efficacy, safety and tolerability of MN-...

Active, not recruiting

Amyotrophic Lateral Sclerosis

Drug: placebo

Drug: MN-166

EXHIT ENTRE Implementation Trial of High Intensity Versus Low Intensity Strategy (EXHITENTRE)

This study is a multi-site, cluster randomized, two group implementation trial comparing a low- versus high-intensity implementation strategy for sup...

Active, not recruiting

Substance Use Disorders

Opioid Use Disorder, Moderate

Other: Low Intensity

Other: High Intensity